V. M. Polonskii
|
|
V.A. Sulimov, D.A. Napalkov
Role Of Sotalol In The Treatment Of Heart Rhythm Disturbances: Modern Approaches
|
16-21 |
I.V. Maev. A.A. Samsonov, N.N. Golubev
Clarithromycin As Inherent Component Of Anti-helicobacter Therapy
|
22-29 |
S.B. Erofeeva
View Of Clinical Pharmacologist On Management Of Patients With The Diseases Of The Hepatobiliary System
|
30-34 |
T.A. Voronina
Mexidol: Main Neuropsychotropic Effects And Mechanisms Of Action
|
35-38 |
L.S. Kanaeva
Potential For Pantogam Use In Medical Practice
|
39-43 |
V.I. Makolkin
Anxiety And Depression As Risk Factors Of Cardiovascular Diseases: Possibilities Of Medicamentous Correction
|
44-48 |
A.F. Loginov, A.V. Kalinin, V.L. Astashov
Pantoprazole Use In The Treatment Of Symptomatic (stress) Gastro-duodenal Ulcerations
|
50-56 |
P.R. Kamchatnov, B.B. Radish, Yu.N. Uchaikin, A.V. Kutenev
Acute Backpain: Analgesic Selection
|
58-63 |
G.R. Tabeeva
Priority Directions In Migraine Treatment
|
64-69 |
E.A. Volskaya
Legal Aspects Of The Prescription Of Drags For Off-label-use
|
70-73 |
V.I. Makolkin
In Spite Of Criticism, Beta- Beta-blockers Remain Preparations Of Selection In The Treatment Of The Cardiovascular Diseases
|
74-78 |
A.L. Vertkin, O.V. Zairatyants, E.I. Vovk
Final Diagnosis: On Renascence Of Clinico-anatomic Conferences
|
79-84 |
A. Yu. Kulikov
Pharmacoeconomic Analysis Of Patients With The Management Of Arterial Hypertension With The Use Of Bisoprolol
|
85-92 |
A.M. Shilov, A. Sh. Avshalumov, V.B. Markovskiy, E.N. Sinitsyna, E.G. Tanaeva, R.U. Baltaeva
Tactics Of Dyslipidemias Treatment In Metabolic Syndrome: Statins Or Fibrates?
|
93-98 |
N.E. Shelepneva, N. Yu. Kashirskaya, V.D. Sherman, N.I. Kapranov
Clinical Significance Of Dornase Alfa (pulmozyme) In Complex Therapy Of Early Age Children Suffering Cystic Fybrosis
|
99-103 |
G.M. Bartashevich
Clinical Experience Of Berlitione Use In Liver Diseases
|
104-106 |
E.I. Chukanova
Encephabol In The Treatment Of Patients With Moderate Cognitive Disturbances
|
107-111 |